Session 4: Which Device is Right? (Device Therapy in Shock)

Friday, April 4, 2025

10:00 AM – 11:30 AM CST

Location: Main Arena

Moderator(s)

NK

Navin Kapur, MD, FAHA, FACC, FSCAI, FHFSA

Professor of Medicine
Tufts University School of Medicine & Tufts Medicine
Stavros Drakos, MD, PhD, FACC

Professor, H.A & Edna Benning Presidential Endowed Chair
UHealth, University of Utah
UHealth, University of Utah
Salt Lake City, Utah, United States

Panelist(s)

Arvind Bhimaraj, MD, MPH, FACC, FHFSA

Associate Professor of Clinical Cardiology
Department of Cardiovascular Sciences
DeBakey Heart & Vascular Center
Houston, Texas, United States
NU

Nir Uriel, MD, MSc, FACC

Seymour, Paul and Gloria Milstein Professor of Medicine
NewYork-Presbyterian / Columbia University Irving Medical Center
New York Presbyterian
New York, New York, United States
Amanda Vest, MBBS, MPH

Section Head
Cleveland Clinic
Cleveland, Ohio, United States
JM

Juan Marcano, MD

Assistant Professor
University of Texas Health Science Center at Houston
Carolyn Rosner, MSN, NP-C, MBA

Director of Innovative Programs
Inova Schar Heart and Vascular
Falls Church, Virginia, United States
Khaled Chatila, MD

Associate Professor, Heart Failure Fellowship program director, APD Internal Medicine residency program.
University of Texas Medical Branch
University of Texas Medical Branch
Galveston, Texas, United States

Disclosure(s):

Stavros Drakos, MD, PhD, FACC: Abbott: Consultant/Advisory Board (Ongoing); Novartis: Research Grant or Support (Ongoing)

Arvind Bhimaraj, MD, MPH, FACC, FHFSA: No financial relationships to disclose

Nir Uriel, MD, MSc, FACC: Abbott: Research Grant or Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abiomed: Consultant/Advisory Board (Ongoing), Research Grant or Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Fire1: Research Grant or Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Leviticus: Advisory Committee/Board Member (Ongoing); Live Metric: Advisory Committee/Board Member (Ongoing); Revamp: Advisory Committee/Board Member (Ongoing)

Amanda R. Vest, MBBS, MPH: CareDx: Research Grant or Support (Terminated, March 1, 2024)

Juan Marcano, MD: No financial relationships to disclose

Carolyn Rosner, MSN, NP-C, MBA: american regeant: Consultant/Advisory Board (Ongoing); Novonordisk: Consultant/Advisory Board (Terminated, December 15, 2023)

Khaled Chatila, MD: No financial relationships to disclose

Presentations:

10:00 AM – 10:07 AM CST

Code Blue on MCS
Speaker: Jamie L. Deneau, APN, MS, CCNS, VAD-C – HCA Healthcare
10:07 AM – 10:15 AM CST

Discussion
10:15 AM – 10:22 AM CST

ECMO First, Ask Questions Later!
Speaker: Erik Osborn, MD, COL, MC USA – American College of Chest Physicians
10:22 AM – 10:30 AM CST

Discussion
10:30 AM – 10:37 AM CST

LV Failure Drives It All - Impella 5.5 for Cardiogenic Shock
Speaker: Mir B. Basir, DO – Henry Ford Health System
10:37 AM – 10:45 AM CST

Discussion
10:45 AM – 10:52 AM CST

AMI-CS: Outcomes of SCAI Stage E
Speaker: William O'Neill, MD – Henry Ford Health System
10:52 AM – 11:00 AM CST

Discussion
11:00 AM – 11:07 AM CST

Tailoring pMCS Based on Kinetics of Shock - Role of Echocardiography and Hemodynamics
Speaker: Esther Vorovich, MD, MSCE – Northwestern University
11:07 AM – 11:15 AM CST

Discussion
11:15 AM – 11:22 AM CST

What Device? Tailoring Medical Therapies for Cardiogenic Shock - Role of Microcirculation
Speaker: Nir Uriel, MD, MSc, FACC – NewYork-Presbyterian / Columbia University Irving Medical Center
11:22 AM – 11:30 AM CST

Discussion